Cross-fund · 4 holders
ENTA
ENANTA PHARMACEUTICALS INC
CUSIP 29251M106
4
Tracked holders
$90.3M
Aggregate value
6,580,892
Shares
5
Active funds
Funds holding ENTA
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $39.2M | — | +27,486 | +0.9% |
| Vanguard | Institutional | Q4 2025 | $36.3M | — | +362,965 | +18.7% |
| Millennium | Multi-Strategy | Q1 2026 | $11.1M | — | +211,669 | +31.6% |
| Citadel | Multi-Strategy | Q1 2026 | $3.7M | — | +181,875 | +163.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -438,939 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.